Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Stojakovic, T; Pichler, M; Gerger, A; Kapp, KS; Langsenlehner, T.
The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients.
World J Urol. 2015; 33(10):1467-1473 Doi: 10.1007/s00345-014-1459-2
Web of Science PubMed FullText FullText_MUG


Führende Autor*innen der Med Uni Graz
Langsenlehner Tanja
Thurner Eva-Maria
Co-Autor*innen der Med Uni Graz
Gerger Armin
Kapp Karin S.
Krenn-Pilko Sabine
Langsenlehner Uwe
Pichler Martin
Stojakovic Tatjana

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Fibrinogen plays an important role in the pathophysiology of tumour cell invasion and metastases. In recent studies, an elevated plasma fibrinogen level has been associated with poor prognosis in different types of cancer. The present study was performed to analyse the prognostic impact of an elevated fibrinogen level in prostate cancer patients. We evaluated data from 268 prostate cancer patients who underwent 3D conformal radiotherapy between 1999 and 2006 at a single tertiary academic center. Cancer-specific survival (CSS), overall survival (OS), and clinical disease-free survival (DFS) were assessed using the Kaplan-Meier method. Univariable and multivariable Cox regression models were performed for each endpoint. Applying receiver operating characteristics (ROC) curve analysis, the optimal cut-off level for the plasma fibrinogen level was 530 mg dl(-1), respectively. Univariable (HR 3.638, 95 % CI 1.15-11.47, p = 0.027) and multivariable analyses (HR 3.964, 95 % CI 1.06-14.87, p = 0.041) revealed a significant correlation between increased plasma fibrinogen and CSS. Univariable analysis also showed a significant association between the elevated plasma fibrinogen level and decreased OS (HR 3.242, 95 % CI 1.53-6.89, p = 0.002), that remained significant in multivariable analysis (HR 3.215, 95 % CI 1.44-7.19, p = 0.004). No significant associations were found for clinical DFS. Although our data show a significant association between an elevated plasma fibrinogen level and poor prostate cancer prognosis, they have to be interpreted cautiously. Limitations of the present study are caused by its retrospective design, the limited accuracy obtained using ROC curve analysis, and potential confounding factors like cardiovascular disease and inflammatory diseases that have not been accounted for.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Aged - epidemiology
Biomarkers, Tumor - blood
Disease Progression -
Disease-Free Survival -
Fibrinogen - metabolism
Follow-Up Studies -
Humans -
Male -
Prognosis -
Proportional Hazards Models -
Prostatic Neoplasms - blood
Prostatic Neoplasms - mortality
Prostatic Neoplasms - radiotherapy
ROC Curve -
Radiotherapy, Conformal -
Retrospective Studies -
Survival Rate - trends

Find related publications in this database (Keywords)
Prostate cancer
© Med Uni Graz Impressum